Dry Mouth Relief Market Research Report - Global Forecast till 2027

Global Dry Mouth Relief Market: Information by Type (Spray, Mouthwash, Gel, Lozenges), Distribution Channel (Pharmacies, E-Commerce, Supermarket) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast till 2027

ID: MRFR/HC/8103-CR | April 2020 | Region: Global | 112 pages

Please note that the assessment period of report has been updated from 2018-2026 to 2020-2027. Cordially fill the sample form for updated data.

Market Overview

Global Dry Mouth Relief Market is expected to register a CAGR of 4.10% to reach USD 2,777.14 Million by 2026. Dry mouth or xerostomia is a condition in which the salivary glands fail to produce and secrete enough saliva to keep the mouth wet. The condition can occur due to various factors such as side-effects of medications, aging, and radiation therapy carried out during cancer.

Market Dynamics

The increasing geriatric population with a number of health problems and high consumption of tobacco & alcohol is expected to drive the market growth. According to the Centers for Disease Control and Prevention, 2018, around 13.7% of adults that is 34.2 million people aged 18 years and above, smoke cigarettes in the US. The side effects of other treatment methods are also anticipated to drive the market growth.

Global Dry Mouth Relief Market, by Distribution Channel, 2019 & 2026 (USD Million) Dry Mouth Relief Market

Source: MRFR Analysis

Dry Mouth Relief Market Segmentation

Global Market has been segmented by Type and Distribution Channel. The market, based on type, has been bifurcated into spray, mouthwash, gel, lozenges, and others.

Based on Distribution Channel, the market has been segregated into pharmacies. E-commerce, and supermarket.

Asia-Pacific Dry Mouth Relief Market Share, 2019 (%) Dry Mouth Relief Market

Source: MRFR Analysis

Regional Analysis

The Global Dry Mouth Relief Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas region is likely to dominate the global market. This can be attributed to the rising patient population suffering from dry mouth or xerostomia in the region. According to an article published by the American Dental Association in July 2019, the prevalence of xerostomia ranges from 0.9% to 64.8%. Moreover, the rising awareness regarding the disease is also expected to drive market growth.

The European market for dry mouth relief is estimated to be the second-largest during the review period. The high growing prevalence of dry mouth as well as its related disorders such as HIV, Sjogren’s syndrome, and rheumatoid arthritis, among others, is expected to boost the growth of the regional market. According to a report published by the Europe PMC in May 2017, the prevalence of Sjogren’s syndrome in Germany is 0.4%, and 20% of the people with Sjogren’s syndrome also suffer from dry mouth. Additionally, the presence of major players such as Sunstar (Switzerland), Fresenius (Germany), Johnson & Johnson Services, Inc. (UK), GlaxoSmithKline PLC (UK), and Sanofi (France) is further fueling the market growth.

Asia-Pacific is estimated to be the fastest-growing market owing to the increasing geriatric population in the region. According to a report published by the United Nations Population Fund (UNFPA), the number of aged people in Asia-Pacific is expected to reach 1.3 billion by 2050. Moreover, the incidence rate of xerostomia is also rising, hence positively affecting market growth.

The market in the Middle East & Africa is expected to witness steady growth due to slowly developing healthcare infrastructure and the increasing government initiatives to manage various healthcare conditions, including dry mouth in the region.

Key Players

The Prominent Players in the Global Market are Johnson & Johnson Services, Inc. (UK), Procter & Gamble (US), GlaxoSmithKline Plc (UK), 3M (US), Colgate-Palmolive (US), Sanofi (France), Mars, Incorporated (US), Bioxtra, Sunstar (Switzerland), Dr. Fresh (California), Xlear (US), Prestige Consumer Healthcare, Inc. (US), Oral Biotech (US), Therabreath (California), Mission Pharmacal Company (US), Fresenius (Germany), and Wisconsin Pharmacal Company (US).

Some of the key strategies followed by players operating in the global market were acquisitions, partnerships, expansion, and product launches.

  • In December 2019, Sunstar announced the expansion of its industrial business in Europe to expand its global footprints.

  • In November 2018, 3M announced the launch of new 3M Xerostomia Relief Spray, which is a clinically proven solution that prevents xerostomia symptoms. The launch of this product will grow companies’ oral health segments.

  • In February 2017, TheraBreath announced the launch of the new TheraBreath Dry Mouth Oral Rinse. The launch of innovative dry mouth products will help the company to grow its dental product portfolio.

Market Segmentation

Global Market, by Type

  • Mouthwash

  • Spray

  • Lozenges

  • Gel

  • Others

Global Market, by Distribution Channel

  • Pharmacies

  • E-Commerce

  • Supermarkets

Global Market, by Region

  • Americas

    • North America

      • US

      • Canada

    • Latin America

      • Brazil

      • Mexico

      • Rest of Latin America

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Russia

    • Poland

    • Belgium

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific

  • Middle East & Africa

    • Middle East

    • Africa

Available Additional Customizations

  • Challenges in the Global Market

  • Pricing Analysis in the Global Dry Mouth Relief Market

Intended Audience

  • Pharmaceutical companies

  • Contract research organizations

  • Research & development organizations

  • Academic institutes

Frequently Asked Questions (FAQ) :

global dry mouth relief market is touted to record a substantial market valuation of USD 2.7 billion by 2025.

global dry mouth relief market is projected to register a moderate 4.10% CAGR in the forecast period.

The remarkable growth for the dry mouth relief market is driven by the growing geriatric population and the growing consumer demand for alcohol and tobacco.

The spray segment is expected to observe substantial demand over the review period.

The APAC is poised to secure the highest CAGR.

The pharmacies segment is slated to mature as the fastest-growing segment.

A few eminent market players functioning in the global dry mouth relief market are General Dynamics Corporation (US), Lockheed Martin Corporation (US), BAE Systems (UK), among others.

This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.